erenumab (aimovig) is the first of four new migraine drugs in the pipeline that target calcitonin gene-related peptide (cgrp), a molecule that's produced in nerve cells of the...

the publication�s purpose is to be a "force for good and a platform for much needed change and to generate critical debate". https://drbryanpwalsh.com/Panciera-mother-of-Kanthak-from-Montral?Mcelhaney=226 .